Phase III StudiesComplete/Considerable Relief

B351

B301

B307

*P < .05 versus placebo.

†P < .01 versus placebo.

*

†

*

*

*

*

†

*

*

†

†

†

†

†

†

†

†

Previous slide

Next slide

Back to first slide

View graphic version